Tables 1A and B Brain metabolite concentrations (mmol/l) and concentration ratios in patients with systemic lupus erythematosus (SLE) and normal subjects.
| tCr | tCho | NAA | mI | |
| Patients with SLE1-152 (n=9) | 6.26 (0.60) | 2.001-150 (0.23) | 9.691-150(1.52) | 6.821-160 (1.40) |
| SLE major (n=5) | 6.21 (0.74) | 1.91 (0.11) | 8.801-165 † (1.31) | 6.871-160 (0.85) |
| SLE minor (n=4) | 6.33 (0.64) | 2.111-150 (0.31) | 10.78† (0.93) | 6.75 (1.98) |
| Lesions1-154(n=4) | 4.86 (1.64) | 1.51 (0.40) | 5.331-165 (3.74) | 5.73 (2.53) |
| Normal subjects‡‡(n=8) | 6.20 (0.28) | 1.78 (0.15) | 11.0 (0.60) | 5.19 (0.66) |
| Table 1B | ||||
| NAA/tCr | mI/tCr | NAA/tCho | NAA/mI | |
| Patients with SLE1-152 (n=9) | 1.56 (0.30) | 1.071-150(0.17) | 4.871-165 (0.77) | 1.531-150 (0.58) |
| Normal subjects‡‡(n=8) | 1.78 (0.15) | 0.84 (0.10) | 6.22 (0.64) | 2.16 (0.33) |
One way analysis of variance of patient groups compared with normal subjects:
↵1-150 p<0.05;
↵1-160 p<0.01;
↵1-165 p<0.005.
One way analysis of variance of SLE major compared with SLE minor:†p<0.05.
↵1-152 Average of all patient data using individual means of data for patients with multiple visits.
Data from normal appearing parietal white matter (NAPWM) in patients with SLE.
↵1-154 Data from large lesions in patients with SLE major.
1-164 Average from NAPWM of eight normal volunteers.